DJIA 16,563.30 -317.06 -1.88%
NASDAQ 4,369.77 -93.13 -2.09%
S&P 500 1,930.67 -39.40 -2.00%
market minute promo

Chimerix (NASDAQ: CMRX)

22.72 -0.78 (-3.32%)

Quote as of


company name or ticker

Recent Quotes

CMRX $22.72 -3.32%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.16
Previous Close $23.50
Daily Range $21.68 - $23.27
52-Week Range $12.96 - $27.69
Market Cap $612.7M
P/E Ratio 1.27
Dividend (Yield) $0.00 (0.0%)
Volume 234,171
Average Daily Volume 315,710
Current FY EPS -$1.78

Sector

Industry

Chimerix (CMRX) Description

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. Website: http://www.chimerix.com/

News & Commentary Rss Feed

Why Chimerix Inc. Shares Jumped

Chimerix delivers a narrower-than-expected third-quarter loss, but here's what shareholders should really have their eyes on.

Thursday 5/29 Insider Buying Report: GLAD, CMRX

Chimerix, Inc. (CMRX) Gains: Stock Up 13.9% - Tale of the Tape

Chimerix, Inc. (CMRX) Gains: Stock Up 13.9% - Tale of the Tape

Weakness Seen in Chimerix (CMRX): Stock Tanks 15.5% - Tale of the Tape

Why Chimerix (CMRX) Stock Is Up Today

What Makes Chimerix (CMRX) a Strong Sell? - Tale of the Tape

Chimerix's (CMRX) CEO Michelle Berrey on Q1 2014 Results - Earnings Call Transcript

Chimerix Is Now Oversold (CMRX)

Increased Earnings Estimates Seen for Chimerix (CMRX): Can It Move Higher? - Tale of the Tape

Chimerix: A Company Focused On Infectious Viral Diseases With Investment Characteristics Similar To

Chimerix: A Company Focused On Infectious Viral Diseases With Investment Characteristics Similar To Trius

Strength Seen in Chimerix (CMRX): Stock Soars 18.2% - Tale of the Tape

See More CMRX News...